| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 16.244 | 19.147 | 22.875 | 15.896 | 51.529 | 24.754 | 41.134 | 66.028 | 78.340 | 64.101 |
| Total Income - EUR | 16.382 | 19.160 | 22.887 | 15.901 | 51.665 | 24.924 | 41.163 | 66.280 | 78.379 | 64.123 |
| Total Expenses - EUR | 15.722 | 18.225 | 19.558 | 15.451 | 38.988 | 24.239 | 39.696 | 51.960 | 57.190 | 56.115 |
| Gross Profit/Loss - EUR | 661 | 935 | 3.329 | 450 | 12.677 | 685 | 1.467 | 14.320 | 21.189 | 8.008 |
| Net Profit/Loss - EUR | 169 | 552 | 3.100 | 291 | 12.160 | 81 | 838 | 13.670 | 20.460 | 6.372 |
| Employees | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 1 |
Check the financial reports for the company - Dr Vis S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 3.551 | 2.728 | 2.233 | 2.743 | 11.208 | 8.854 | 6.722 | 5.745 | 5.345 | 5.342 |
| Current Assets | 13.819 | 3.363 | 6.078 | 5.726 | 6.478 | 5.729 | 2.456 | 13.357 | 21.116 | 24.881 |
| Inventories | 200 | 16 | 55 | 124 | 0 | 2.728 | 50 | 535 | 1.338 | 198 |
| Receivables | 12.282 | 2.394 | 1.176 | 736 | 242 | 440 | 563 | 430 | 8.142 | 9.307 |
| Cash | 1.337 | 953 | 4.848 | 4.866 | 6.236 | 2.561 | 1.843 | 12.392 | 11.637 | 15.375 |
| Shareholders Funds | 16.703 | 5.283 | 7.751 | 4.857 | 16.923 | 11.374 | 6.825 | 17.979 | 24.755 | 28.804 |
| Social Capital | 225 | 222 | 219 | 215 | 211 | 207 | 202 | 203 | 202 | 201 |
| Debts | 667 | 808 | 560 | 3.612 | 762 | 3.209 | 2.353 | 1.123 | 1.706 | 1.418 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8623 - 8623" | |||||||||
| CAEN Financial Year |
8623
|
|||||||||
Comments - Dr Vis S.r.l.